Annual Report 2022

REPORT OF THE DIRECTORS 28 The United Laboratories International Holdings Limited Annual Report 2022 DIRECTORS’ INTERESTS IN COMPETING BUSINESS AND CONTRACTS None of the directors have any interests in a business which competes with the business of the Group. Furthermore, no contracts of significance in relation to the Group’s business in which a director of the Company had a material interest, whether directly or indirectly, subsisted at the end of the year or at any time during the year. DIRECTORS’ AND CHIEF EXECUTIVE’S INTERESTS AND SHORT POSITIONS IN SHARES, UNDERLYING SHARES AND DEBENTURES As at 31 December 2022, the directors and chief executive of the Company had the following interests or short positions in the shares, underlying shares or debentures of the Company or any of its associated corporations (within the meaning of Part XV of the Securities and Futures Ordinance (“SFO”) as recorded in the register required to be kept by the Company under section 352 of the SFO or as otherwise notified to the Company and the Stock Exchange pursuant to the Model Code for Securities Transactions by Directors of Listed Companies (“Model Code”): Long position in the ordinary shares of the Company: Name of directors Number of shares Capacity Percentage of interest Mr. Tsoi Hoi Shan 16,306,875 Personal interest 0.90% Mr. Leung Wing Hon 22,000 Personal interest 0.00% Ms. Choy Siu Chit 117,875 Personal interest 0.01% Ms. Zou Xian Hong 200,000 Personal interest 0.01% Ms. Zhu Su Yan 179 Personal interest 0.00% Save as disclosed above, none of the directors, chief executive and their associates had any interests or short position in the shares, underlying shares or debentures of the Company or any of its associated corporations, within the meaning of Part XV of the SFO, as recorded in the register required to be kept by the Company under section 352 of the SFO, or as otherwise notified to the Company and the Stock Exchange pursuant to the Model Code.